Deslorelin

地洛瑞林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDeslorelin
Drug Alias Name德舍瑞林deslorelinumdeslorelinaSomagardD-Trp-LHRH-PEA +[6] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGonadotropin-releasing hormone agonists
TargetsGonadotropin-releasing hormone
Therapy Area/IndicationsGrowth DisordersEndometriosisDwarfism +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human Development
Active IndicationsEndometriosisProstatic Neoplasms
Inactive IndicationsGrowth DisordersDwarfism

Other Information

ATC CodeH01CA
Related LinksWikipediaKEGG